A randomized controlled trial to evaluate the effectiveness and cost-effectiveness of exercise interventions after chemotherapy on physical fitness, fatigue and quality of life.
Completed
- Conditions
- breast cancercervix cancercolon cancerovarian cancertestis cancer or lymphomas cancer10006291
- Registration Number
- NL-OMON39339
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 280
Inclusion Criteria
Patients with histological confirmed primary breast, colon, ovarian, cervix, testis cancer or lymphomas with no indication of recurrent or progressive disease, who completed ((neo)adjuvant) chemotherapy with curative intention, are eligible for this study.
Exclusion Criteria
Patients who are not able to perform basic activities such as walking or biking, who show cognitive disorders or severe emotional instability, who are suffering from other disabling comorbidity that might hamper physical performance capacity ( e.g. heart failure, chronic obstructive pulmonary disease (COPD), orthopaedic conditions and neurological disorders), and patients who are unable to understand and read the Dutch language will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Cardiorespiratory fitness, muscle strength and fatigue.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary outcome variables include body composition and bone mineral density,<br /><br>health-related quality of life, physical activity<br /><br>level, satisfaction with the intervention, mood disturbances, sleep quality,<br /><br>functioning in daily life and return to work.</p><br>